1. Home
  2. HCM vs MYRG Comparison

HCM vs MYRG Comparison

Compare HCM & MYRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • MYRG
  • Stock Information
  • Founded
  • HCM 2000
  • MYRG 1891
  • Country
  • HCM Hong Kong
  • MYRG United States
  • Employees
  • HCM N/A
  • MYRG N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • MYRG Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • HCM Health Care
  • MYRG Industrials
  • Exchange
  • HCM Nasdaq
  • MYRG Nasdaq
  • Market Cap
  • HCM 2.3B
  • MYRG 2.3B
  • IPO Year
  • HCM N/A
  • MYRG N/A
  • Fundamental
  • Price
  • HCM $16.11
  • MYRG $120.50
  • Analyst Decision
  • HCM Hold
  • MYRG Strong Buy
  • Analyst Count
  • HCM 1
  • MYRG 5
  • Target Price
  • HCM $19.00
  • MYRG $162.40
  • AVG Volume (30 Days)
  • HCM 71.4K
  • MYRG 157.8K
  • Earning Date
  • HCM 03-19-2025
  • MYRG 02-26-2025
  • Dividend Yield
  • HCM N/A
  • MYRG N/A
  • EPS Growth
  • HCM N/A
  • MYRG N/A
  • EPS
  • HCM N/A
  • MYRG 2.29
  • Revenue
  • HCM $610,806,000.00
  • MYRG $3,536,692,000.00
  • Revenue This Year
  • HCM N/A
  • MYRG N/A
  • Revenue Next Year
  • HCM $15.89
  • MYRG $2.93
  • P/E Ratio
  • HCM N/A
  • MYRG $55.63
  • Revenue Growth
  • HCM N/A
  • MYRG 0.94
  • 52 Week Low
  • HCM $12.84
  • MYRG $86.60
  • 52 Week High
  • HCM $21.92
  • MYRG $181.02
  • Technical
  • Relative Strength Index (RSI)
  • HCM 68.69
  • MYRG 29.08
  • Support Level
  • HCM $13.58
  • MYRG $130.40
  • Resistance Level
  • HCM $13.96
  • MYRG $137.10
  • Average True Range (ATR)
  • HCM 0.31
  • MYRG 5.85
  • MACD
  • HCM 0.34
  • MYRG -1.84
  • Stochastic Oscillator
  • HCM 89.84
  • MYRG 2.48

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About MYRG MYR Group Inc.

MYR Group Inc is a U.S.-based holding company that provides specialty electrical construction services through its subsidiaries. The company operates through two segments. The transmission and distribution segment provides designing, engineering, procurement, construction, upgrade, maintenance, and repair services on transmission and distribution network and substation facilities. The commercial and industrial segment provides services such as the design, installation, maintenance, and repair of commercial and industrial wiring, installation of traffic networks, and the installation of bridges. MYR Group generates the majority of its sales from the United States and Canada.

Share on Social Networks: